Low birth volume fuels rural healthcare obstetric closures, limiting women’s health access—see which hospitals are most at risk.
|Articles|July 1, 2002
Inspector General questions Rx drug coverage information
Washington, D.C. - Medicare+Choice plans do a poor job explaining the intricacies of drug coverage plans to seniors, according to a report from the Office of the Inspector General (OIG) in the Department of Health and Human Services (HHS) ("Medicare HMO Prescription Drug Benefits," May 2002, OEI-03-00-00430, at http://oig.hhs.gov/oei/reports).
Advertisement
Advertisement
Related to this article
In both mice and human cells, a small molecule selectively blocked the activity of MAP4K4, a protein involved in several major biological pathways.
Steering claims away from 340B-eligible pharmacies is one option but also the most disruptive, said Jeff Dunn, Pharm.D., MBA, of NeosRx.
340B discounts preclude rebates paid to pharmacy benefit managers for their payer clients. Dunn says new transparency and cost pressures have created awareness of “340B rebate erosion.”
Onswik is approved to improve glycemic control in adults with Type 2 diabetes and will be available in the United States in the coming months in two concentrations. No information is available on the list price.
A meta-analysis of 13 trials and 969 patients saw some short-term reductions in cancer-related pain and anxiety, especially during procedures, when using virtual reality.
Chad Hatfield, Pharm.D., M.H.A., BCPS, vice president and chief pharmacy officer of UC Davis Health, says pharmacists are embedded in “nearly all specialties," with more than 150 holding board certification.
A new Spherix Global Insights survey shows providers want administrative support for prior authorization while patients prioritize access and affordability
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Survey identifies what doctors and patients want from support programs
2
Virtual reality could become new treatment tool for cancer pain and anxiety, meta-analysis finds
3
Chad Hatfield, Pharm.D., on embedding pharmacists across specialties in the UC Davis Health System
4
The Future of Employer Health Benefits Is Connected Care
5